☆ 4.0 Article

COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?

TRANSFUSION CLINIQUE ET BIOLOGIQUE (2021)

Related references

Note: Only part of the references are listed.

Article Immunology

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

Ji Hoon Baang et al.

Summary: This case illustrates challenges in managing immunocompromised hosts with chronic COVID-19, who may act as persistent shedders and sources of transmission. The patient's lack of seroconversion and prolonged course highlight the importance of humoral immunity in resolving viral infections.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Biochemical Research Methods

CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department

Penelope Bourgoin et al.

Summary: The study found that nCD64 and mCD169 can effectively distinguish bacterial infections and acute viral infections, potentially improving infection management in the ED and aiding in patient triage during emerging epidemics.

CYTOMETRY PART A (2021)

Add to Collection

Letter Immunology

Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy

Jonathan London et al.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

R. Libster et al.

Summary: A randomized, double-blind, placebo-controlled trial of convalescent plasma with high IgG titers against SARS-CoV-2 in older adult patients within 72 hours after the onset of mild Covid-19 symptoms found that early administration of high-titer convalescent plasma reduced the progression of Covid-19 in mildly ill infected older adults.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Biochemical Research Methods

Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus

Marija Brgles et al.

Summary: This study examined the neutralization capacity of human sera and therapeutic immunoglobulins against mumps and measles virus, finding that different methods of measurement yielded diverse results without complete correlation. Heat inactivation of sera had varying impacts on neutralization capacity, while the complement system played a significant role in neutralizing mumps virus.

JOURNAL OF IMMUNOLOGICAL METHODS (2021)

Add to Collection

Article Immunology

Production of hyperimmune anti-SARS-CoV-2 intravenous immunoglobulin from pooled COVID-19 convalescent plasma

Shaukat Ali et al.

Summary: This study successfully produced hyperimmune anti-COVID-19 intravenously administrable immunoglobulin (C-IVIG) with high titers of SARS-CoV-2 antibody using simple technology and locally available pooled convalescent plasma. The safety and efficacy of C-IVIG will be evaluated in a registered clinical trial.

IMMUNOTHERAPY (2021)

Add to Collection

Review Medicine, Research & Experimental

SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis

Parisa Shiri Aghbash et al.

Summary: The COVID-19 pandemic, caused by the outbreak of SARS-CoV-2 in Wuhan in December 2019, highlights the significance of respiratory disorders, lymphopenia, cytokine cascades, and immune responses in disease severity. Investigation of inhibitory immune checkpoints could impact treatment strategies, with T-cells playing a key role in clearing viral infections and reducing symptoms. Lymphocyte depletion and enhanced expression of inhibitory immune checkpoints in individuals with COVID-19 contribute to T-cell dysfunction and exhaustion, particularly in severe cases.

LIFE SCIENCES (2021)

Add to Collection

Article Cell Biology

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

Kazuhito Honjo et al.

Summary: Convalescent plasma (CP) has beneficial effects in severely ill COVID-19 patients, even when administered relatively late in the disease course. However, there are widely varying neutralizing antibody (NAbs) titers within different CP units, highlighting the importance of determining neutralizing activity for maximizing therapeutic benefits.

CELL REPORTS MEDICINE (2021)

Add to Collection

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Add to Collection

Article Immunology

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)

Bo Diao et al.

FRONTIERS IN IMMUNOLOGY (2020)

Add to Collection

Correction Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China (vol 579, pg 265, 2020)

Fan Wu et al.

NATURE (2020)

Add to Collection

Review Hematology

Convalescent plasma therapy in patients withCOVID-19

Tugce Nur Yigenoglu et al.

JOURNAL OF CLINICAL APHERESIS (2020)

Add to Collection

Review Critical Care Medicine

Lymphopenia in severe coronavirus disease-2019 (COVID-19): systematic review and meta-analysis

Ian Huang et al.

JOURNAL OF INTENSIVE CARE (2020)

Add to Collection

Article Hematology

Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19

Thomas Hueso et al.

BLOOD (2020)

Add to Collection

Review Immunology

Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience

Kanta Subbarao et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Add to Collection

Review Hematology

Treatment for emerging viruses: Convalescent plasma and COVID-19

Bethany L. Brown et al.

TRANSFUSION AND APHERESIS SCIENCE (2020)

Add to Collection

Letter Immunology

Lymphopenia during the COVID-19 infection: What it shows and what can be learned

Soheil Tavakolpour et al.

IMMUNOLOGY LETTERS (2020)

Add to Collection

Letter Allergy

Three patients with X-linked agammaglobulinemia hospitalized for COVID-19 improved with convalescent plasma

Haoli Jin et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Case Study: Prolonged Infectious SARS-CoV-2 Shedding from an Asymptomatic Immunocompromised Individual with Cancer

Victoria A. Avanzato et al.

CELL (2020)

Add to Collection

Article Medicine, Research & Experimental

SARS-CoV-2-specific T cell responses and correlations with COVID-19 patient predisposition

Arne Sattler et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Add to Collection

Review Biochemical Research Methods

Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review

Ihsane Benlyamani et al.

CYTOMETRY PART A (2020)

Add to Collection

Article Medicine, General & Internal

A 63-Year-Old Woman with a History of Non-Hodgkin Lymphoma with Persistent SARS-CoV-2 Infection Who Was Seronegative and Treated with Convalescent Plasma

Joanna L. Moore et al.

AMERICAN JOURNAL OF CASE REPORTS (2020)

Add to Collection

Article Hematology

Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow

O. Garraud et al.

TRANSFUSION CLINIQUE ET BIOLOGIQUE (2016)

Add to Collection

Article Immunology

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Darren M. Roberts et al.

JOURNAL OF AUTOIMMUNITY (2015)

Add to Collection

Article Biotechnology & Applied Microbiology

Factors influencing preclinical in vivo evaluation of mumps vaccine strain immunogenicity

B. Halassy et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Add to Collection

Article Transplantation

Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study

Mathias Streitz et al.

TRANSPLANTATION RESEARCH (2013)

Add to Collection

© Peeref 2019-2024. All rights reserved.